Published by Josh White on 4th May 2020
(Sharecast News) - Pharmaceutical services company Open Orphan announced the signing of a new contract with an unnamed US biotechnology company on Monday, for the provision of a respiratory syncytial virus (RSV) human challenge study.
URL: http://www.digitallook.com/dl/news/story/30616744/...